We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Dermatology

Expert Opinion / Commentary · July 10, 2014

A Strong Case for Photographic Surveillance of Patients at High Risk for Cutaneous Melanoma

Written by
Arthur R. Rhodes MD, MPH

 

Additional Info

  1. Moloney FJ, Guitera P, Coates E, et al Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study [published online ahead of print June 25, 2014]. JAMA Dermatol. doi:10.1001/jamadermatol.2014.514.
  2. Cohen MH, Cohen BJ, Shotkin JD, Morrison PT. Surgical prophylaxis of malignant melanoma. Ann Surg. 1991;213(4):308-314.

  3. Carli P, De Giorgi V, Chiarugi A, et al Addition of dermoscopy to conventional naked-eye examination in melanoma screening. J Am Acad Dermatol. 2004;50(5):683-689.
  4. Carli P, De Giorgi V, Crocetti E, et al Improvement of malignant/benign ratio in excised melanocytic lesions in the "dermoscopy era': a retrospective study 1997-2001. Br J Dermatol. 2004;150(4):687-692.
  5. Menzies SW, Emery J, Staples M, et al Impact of dermoscopy and short-term sequential digital dermoscopy imaging for the management of pigmented lesion in primary care. Br J Dermatol. 2009;161(6):1270-1277.
  6. Fisher NM, Schaffer JV, Berwick M, Bolognia JL. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol. 2005;53(3):393-406.
  7. Marks R, Jolley D, McCormack C, Dorevitch AP. Who removes pigmented skin lesions? A study of the ratio of melanoma to other benign pigmented tumors removed by different categories of physicians in Australia in 1989 and 1994. J Am Acada Dermatol. 1997;36(5 Pt 1):721-726.
  8. Banky JP, Kelly JW, English DR, et al. Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol. 2005;141(8):998-1006.
  9. Nathansohn N, Orenstein A, Trau H, et al. Pigmented lesions clinic for early detection of melanoma: preliminary results. Isr Med Assoc J. 2007;9(10):708-712.
  10. Goodson AG, Florell SR, Hyde M, et al. Comparative analysis of total body and dermatoscopic photographic monitoring of nevi in similar patient populations at risk for cutaneous melanoma. Dermatol Surg. 2010;36(7)1087-1098.
  11. Feit NE, Dusza SW, Marghoob AA. Melanomas detected with the aid of total cutaneous photography. Br J Dermatol. 2004;150(4):706-714.
  12. Haenssle HA Vente C, Bertsch HP, et al. Results of a surveillance program me for patients at high risk of malignant melanoma using digital and conventional dermoscopy. Euro J Canc Prev. 2004;13(2):133-138.
  13. Buhl T, Hansen-Hagge C, Korpas B, et al. Integrating static and dynamic features of melanoma: the DynaMel algorithm. J Am Acad Dermatol. 2012;66(1):27-36.
  14. Salerni G, Carrera C, Lovatto L, et al. Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma. J Am Acad Dermatol. 2012;67(1):e17-e27.
  15. Hansson J, Bergenmar M, Hofer P-A, et al. Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program. J Clin Oncol. 2007;25(19):2819-2824.
  16. Lucas CR, Sanders LL, Murray JC, et al. Early melanoma detection: nonuniform dermoscopic features and growth. J Am Acad Dermatol. 2003;48(5):663-671.

  17. Kelly JW, Yeatman JM, Regalia C, et al. A high incidence of melanoma found in patients with multiple dysplastic naevi by photographic surveillance. Med J Austral. 1997;167(4):191-194.

  18. Argenziano G, Mordente I, Ferrara G, et al. Dermoscopic monitoring of melanocytic skin lesions: clinical outcome and patient compliance vary according to follow-up protocols. Brit J Dermatol. 2008;159(2):331-336.
  19. Altamura D, Avramidis M, Menzies SW. Assessment of the optimal interval for and sensitivity of short-term sequential digital dermoscopy monitoring for the diagnosis of melanoma. Arch Dermatol. 2008;144(4):502-506.
  20. Haenssle HA, Korpas B, Hansen-Hagge C, et al. Selection of patients for long-term surveillance with digital dermoscopy by assessment of melanoma risk factors. Arch Dermatol. 2010;146(3):257-264.
  21. Kovalyshyn I, Dusza SW, Siamas K, Halpern AC, et al. The impact of physician screening on melanoma detection. Arch Dermatol. 2011;147(11):1269-1275.
  22. Sidhu S, Bodger O, Williams N, Roberts DL. The number of benign moles excised for each malignant melanoma: the number needed to treat. Clin Experimental Dermatol. 2011;37(1):6-9.
  23. Argenziano G, Cerroni L, Zalaudek I, et al. Accuracy in melanoma detection: a 10 year multicenter survey. J Am Acad Dermatol. 2012;67(1):54-59.
  24. Nehal KS, Oliveria SA, Marghoob AA, et al. Use of and beliefs about baseline photography in the management of patients with pigmented lesions: a survey of dermatology residency programmes in the United States. Melanoma Res. 2002;12(2):161-167.
  25. Terushkin V, Oliveria SA, Marghoob AA, Halpern AC. Use of and beliefs about total body photography and dermatoscopy among US dermatology training programs: an update. J Am Acad Dermatol. 2010;62(5):794-803.

Further Reading